💊
Abraxane
paclitaxel
Neoplasie mammarie;Neoplasie pancreatiche;Carcinoma polmonare non a piccole cellule
✅ Autorizzato
✅
Nessun allarme attivo
Questo medicinale non presenta carenze in corso, lettere di sicurezza o richiami.
A cosa serve
Abraxane monotherapy is indicated for the treatment of metastatic breast cancer in adult patients who have failed first-line treatment for metastatic disease and for whom standard, anthracycline containing therapy is not indicated. Abraxane in combination with gemcitabine is indicated for the first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas. Abraxane in combination with carboplatin is indicated for the first-line treatment of non-small cell lung cancer in adult patients who are not candidates for potentially curative surgery and/or radiation therapy.
⚠️ Sicurezza del paziente
No
📚 Avvisi passati (2)
Pagina ufficiale EMA
https://www.ema.europa.eu/en/medicines/human/EPAR/abraxane